Acquired dysfibrinogenaemia in acute and chronic liver disease.
Plasma from patients with both acute and chronic liver disease has been examined for evidence of acquired dysfibrinogenaemia, using electrophoretic methods and coagulation tests. An examination of isolated fibrins upon SDS polyacryamide gel electrophoresis failed to demonstrate any molecular or structural defect associated with the polypeptide chains of the patients' fibrinogen or fibrinogen derivatives produced by thrombin or plasmin. However, purified fibrin monomers isolated from plasma using both Reptilase and thrombin exhibited delayed polymerization rates and the occurrence of acquired dysfibrinogenaemia in liver disease is therefore confirmed.
D000208:Acute Disease; D000721:Ancrod / Q000378:metabolism; D012103:Batroxobin / Q000378:metabolism; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D002908:Chronic Disease; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D013917:Thrombin / Q000378:metabolism
D005337:Fibrin; D005340:Fibrinogen; D000721:Ancrod; D012103:Batroxobin; D013917:Thrombin